Search details
1.
Predictive Value of Total Metabolic Tumor Burden Prior to Treatment in NSCLC Patients Treated with Immune Checkpoint Inhibition.
J Clin Med
; 12(11)2023 May 28.
Article
in English
| MEDLINE | ID: mdl-37297920
2.
Additional Primary Tumors Detected Incidentally on FDG PET/CT at Staging in Patients with First Diagnosis of NSCLC: Frequency, Impact on Patient Management and Survival.
Cancers (Basel)
; 15(5)2023 Feb 28.
Article
in English
| MEDLINE | ID: mdl-36900312
3.
An Innovative Non-Linear Prediction Model for Clinical Benefit in Women with Newly Diagnosed Breast Cancer Using Baseline FDG-PET/CT and Clinical Data.
Cancers (Basel)
; 15(22)2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-38001736
4.
Predictive Value of Baseline FDG-PET/CT for the Durable Response to Immune Checkpoint Inhibition in NSCLC Patients Using the Morphological and Metabolic Features of Primary Tumors.
Cancers (Basel)
; 14(24)2022 Dec 11.
Article
in English
| MEDLINE | ID: mdl-36551581
Results
1 -
4
de 4
1
Next >
>>